FRA/TKD (FRA/TKD)

Frankfurt Stock Exchange: FRA/TKD · EUR

€36.2

-0.20 (-0.6%)· Recorded snapshot

Market cap	57.2B
Revenue (ttm)	24.9B
Net income (ttm)	-880.1M
EPS (ttm)	-€0.59
Dividend	€1.11 (3.07%)
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 24.9B
Net income (ttm): -880.1M
EPS (ttm): -€0.59
Market cap: 57.2B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-2.3

P25 n/aP50 n/aP75 n/a

ROIC5.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All FRA/TKD indicators

Market & fundamental data

Available fields

235

Groups with data

Currency

JPY

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Japan
Country code	DE
Earnings date	2026-10-29
Employees	47,029
Employees change	-426
Employees growth	-0.9%
Enterprise value	EUR 86.1B
Exchange	Frankfurt Stock Exchange
Financial currency	JPY
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	1781
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	JP3463000004
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Market cap	EUR 57.2B
Next earnings date	2026-10-29
Price	EUR 36.18
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	fra/TKD
Website	https://www.takeda.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	55.53x
Average P/E ratio (3Y)	60.13x
Average P/E ratio (5Y)	42.97x
Earnings yield	-1.63%
EV/EBIT	23.73x
EV/EBITDA	11.67x
EV/FCF	20.72x
EV/Sales	3.28x
FCF / EV yield	4.83%
FCF yield	7.26%
Industry forward P/E	17.12x
Industry P/E	27.78x
P/(FCF - SBC) ratio	15.25x
P/(OCF - SBC) ratio	12.09x
P/B ratio	1.41x
P/FCF ratio	13.78x
P/OCF ratio	11.15x
P/S ratio	2.3x
Price/EBITDA ratio	8.51x
Sector forward P/E	14.8x
Sector P/E	39.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	13.85%
EBITDA margin	27.05%
FCF margin	15.8%
Gross margin	64.47%
Operating margin	13.85%
Pretax margin	-2.82%
Profit margin	-3.54%
Profit per employee	EUR -18,714
Profitable quarters	1
Profitable years	11
Revenue per employee	EUR 528,883
ROA	2.69%
ROA (5Y)	2.57%
ROCE	4.96%
ROE	-2.26%
ROE (5Y)	2.21%
ROIC	5.13%
ROIC (5Y)	4.47%
SBC / revenue	1.61%
Tax / revenue	0.71%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (Q)	-9.83%
EPS growth years	1
FCF growth	-15.29%
FCF growth (Q)	-55.94%
FCF growth (QoQ)	162.06%
FCF growth 3Y	-2.82%
FCF growth 5Y	-3.33%
Gross profit growth	2.29%
Gross profit growth (Q)	12.63%
Gross profit growth 3Y	1.68%
Gross profit growth 5Y	5.05%
Net income growth (Q)	-8.89%
Net income growth years	1
OCF growth	-13.49%
OCF growth (Q)	-40.76%
OCF growth (QoQ)	71.24%
OCF growth 10Y	32.4%
OCF growth 3Y	-1.08%
OCF growth 5Y	-1.57%
Operating income growth	18.13%
Operating income growth (Q)	18.74%
Operating income growth 3Y	0.52%
Operating income growth 5Y	4.2%
Revenue growth	3.1%
Revenue growth (Q)	10.23%
Revenue growth (QoQ)	11.45%
Revenue growth 10Y	9.91%
Revenue growth 3Y	3.94%
Revenue growth 5Y	6.66%
Revenue growth quarters	3
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -979.5M
Depreciation and amortization	EUR 3.5B
EBIT	EUR 3.4B
EBITDA	EUR 6.7B
EPS	EUR -0.59
Financing cash flow	EUR -2.5B
Free cash flow	EUR 4.2B
Free cash flow minus SBC	EUR 3.8B
Gross profit	EUR 16B
Income taxes	EUR 177.1M
Investing cash flow	EUR -2.3B
Net borrowing	EUR -58.3M
Net cash flow	EUR 597.6M
Net income	EUR -880.1M
Operating cash flow minus SBC	EUR 4.7B
Operating income	EUR 3.4B
Revenue	EUR 24.9B
Stock-based compensation	EUR 400.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.09
Book value per share	EUR 25.75
Debt / EBITDA	4.26
Debt / equity	0.73
Debt / FCF	7.17
Goodwill	EUR 33.5B
Interest coverage	3.43
Long-term assets	EUR 66.4B
Long-term liabilities	EUR 27.9B
Net cash (debt)	EUR -27.3B
Net cash / market cap	-47.74%
Net debt / EBITDA	4.06
Net debt / equity	0.67
Net debt / FCF	6.58
Piotroski F-Score	4
Property, plant and equipment	EUR 12.2B
Shareholders' equity	EUR 40.7B
Tangible book value	EUR -9.3B
Tangible book value per share	EUR -5.86
Total assets	EUR 84.3B
Total cash	EUR 2.5B
Total debt	EUR 29.8B
Total liabilities	EUR 43.6B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.31
Current assets	EUR 17.9B
Current liabilities	EUR 15.7B
Current ratio	1.14
Inventory turnover	1.22
Net working capital	EUR 2.4B
Quick ratio	0.51
Working capital	EUR 2.1B
Working capital turnover	0.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.64%
Dividend growth	-5.25%
Dividend growth (10Y)	-3%
Dividend growth (3Y)	-3.17%
Dividend growth (5Y)	-4.35%
Dividend growth years	0
Dividend payment date	2026-12-01
Dividend payment years	24
Dividend payout frequency	Semi-Annual
Dividend per share	EUR 1.11
Dividend yield	3.07%
Ex-dividend date	2026-09-29
Last dividend	EUR 0.57
Shareholder yield	4.71%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-13.37%
10Y return CAGR	2.84%
10Y total return	32.3%
150-day SMA	EUR 30.01
15Y price change	9.26%
15Y return CAGR	4.78%
15Y total return	101.37%
1D price change	-0.55%
1M price change	11.26%
1M total return	13.22%
1W price change	4.87%
1W total return	4.87%
1Y price change	51%
1Y return CAGR	56.42%
1Y total return	56.37%
20-day SMA	EUR 33.79
200-day SMA	EUR 29.99
3M price change	20.56%
3M total return	22.68%
3Y price change	40.78%
3Y return CAGR	16.87%
3Y total return	59.63%
50-day SMA	EUR 32.58
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 36.38
52-week high date	2026-10-26
52-week low	EUR 22.45
52-week low date	2025-10-30
5Y price change	49.81%
5Y return CAGR	13.23%
5Y total return	86.09%
6M price change	27.71%
6M total return	29.96%
All-time high	EUR 50.45
All-time high date	2015-03-06
All-time low	EUR 22.45
All-time low date	2025-10-30
Average true range (ATR)	EUR 0.61
Average volume	548.8
Change from 52-week high	-0.55%
Change from 52-week low	61.16%
Change from all-time high	-28.29%
Change from all-time low	61.16%
Change from open	0%
Day's gap	-0.55%
High price	EUR 36.18
Low price	EUR 36.18
Monthly RSI	71
Open price	EUR 36.18
Previous close	EUR 36.38
Price vs 150-day SMA	20.55%
Price vs 20-day SMA	7.09%
Price vs 200-day SMA	20.62%
Price vs 50-day SMA	11.04%
Relative volume	0.2
RSI	69.64
Sharpe ratio	1.49
Sharpe ratio (3Y)	0.58
Sharpe ratio (5Y)	0.43
Sortino ratio	2.52
Sortino ratio (3Y)	1.11
Sortino ratio (5Y)	0.89
Volume	0
Weekly RSI	73.57
YTD price change	39.48%
YTD total return	44.44%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.6B
Shares change (QoQ)	1.56%
Shares change (YoY)	-1.64%
Shares held by insiders	0.12%
Shares held by institutions	50.7%

Deeper analysis on FRA/TKD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this FRA/TKD report

Is a complete FRA/TKD research report available?

No complete published report is available for fra/TKD (FRA/TKD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

FRA/TKD (FRA/TKD)

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/TKD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/TKD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on FRA/TKD

Frequently asked questions